CD38 and COVID-19: In previous studies involving COVID-19 patients, an overactivation of the immune system by HLA-DR+CD38+ T cells was found, even 12 months after infection (36), probably due to both the initial lymphopenia and the role these cells play in providing help to B lymphocytes (37–39).